BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 5492246)

  • 1. Quantitative measurement of iron stores with diethylenetriamine penta-acetic acid.
    Barry M; Cartei G; Sherlock S
    Gut; 1970 Nov; 11(11):891-8. PubMed ID: 5492246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of iron stores in cirrhosis using diethylenetriamine penta-acetic acid.
    Barry M; Cartei G; Sherlock S
    Gut; 1970 Nov; 11(11):899-904. PubMed ID: 5492247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of diethylenetriamine penta-acetic acid (D.T.P.A.) in the clinical assessment of total body iron stores.
    Powell LW; Thomas MJ
    J Clin Pathol; 1967 Nov; 20(6):896-904. PubMed ID: 5614075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of storage iron by chelates.
    Harker LA; Funk DD; Finch CA
    Am J Med; 1968 Jul; 45(1):105-15. PubMed ID: 5658862
    [No Abstract]   [Full Text] [Related]  

  • 5. Deferoxamine-chelatable iron in hemochromatosis and other disorders of iron overload.
    Baldus WP; Fairbanks VF; Dickson ER; Baggenstoss AH
    Mayo Clin Proc; 1978 Mar; 53(3):157-65. PubMed ID: 628226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of storage iron as body stores expand in patients with hemochromatosis.
    Valberg LS; Simon JB; Manley PN; Corbett WE; Ludwig J
    J Lab Clin Med; 1975 Sep; 86(3):479-89. PubMed ID: 1151163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DIFFERENTIAL FERRIOXAMINE TEST FOR MEASURING CHELATABLE BODY IRON.
    FIELDING J
    J Clin Pathol; 1965 Jan; 18(1):88-97. PubMed ID: 14247711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron overload disorders: natural history, pathogenesis, diagnosis, and therapy.
    McLaren GD; Muir WA; Kellermeyer RW
    Crit Rev Clin Lab Sci; 1983; 19(3):205-66. PubMed ID: 6373141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron chelation using subcutaneous infusions of diethylene triamine penta-acetic acid (DTPA).
    Pippard MJ; Jackson MJ; Hoffman K; Petrou M; Modell CB
    Scand J Haematol; 1986 May; 36(5):466-72. PubMed ID: 3738427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential ferrioxamine test in haemochromatosis and liver diseases.
    Barry M; Cartei G; Sherlock S
    Gut; 1969 Sep; 10(9):697-704. PubMed ID: 5386626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic iron clearance from serum in treated hemochromatosis.
    Batey RG; Pettit JE; Nicholas AW; Sherlock S; Hoffbrand AV
    Gastroenterology; 1978 Nov; 75(5):856-9. PubMed ID: 700326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The assessment of total body iron stores using the chelating agent diethylene-triamine penta-acetic acid (D.T.P.A.). Its significance for human haemochromatosis.
    Powell LW
    Rev Med Chir Mal Foie; 1966 Dec; 41(6):271-80. PubMed ID: 5992828
    [No Abstract]   [Full Text] [Related]  

  • 13. IDIOPATHIC HAEMOCHROMATOSIS IN MENSTRUATING WOMEN. A FAMILY STUDY, INCLUDING THE USE OF DIETHYLENE TRIAMINE PENTA-ACETIC ACID.
    LLOYD HM; POWELL LW; THOMAS MJ
    Lancet; 1964 Sep; 2(7359):555-7. PubMed ID: 14172348
    [No Abstract]   [Full Text] [Related]  

  • 14. Cobalt excretion test for the assessment of body iron stores.
    Sorbie J; Olatunbosun D; Corbett WE; Valberg LS
    Can Med Assoc J; 1971 May; 104(9):777-82. PubMed ID: 5578125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of hepatic iron concentration to histochemical grading and to total chelatable body iron in conditions associated with iron overload.
    Walker RJ; Miller JP; Dymock IW; Shilkin KB; Williams R
    Gut; 1971 Dec; 12(12):1011-4. PubMed ID: 5157130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential ferrioxamine test in idiopathic haemochromatosis and transfusional haemosiderosis.
    Fielding J; O'Shaughnessy MC; Brunström GM
    J Clin Pathol; 1966 Mar; 19(2):159-64. PubMed ID: 5909697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron absorption in hemochromatosis before and after phlebotomy therapy.
    Sargent T; Saito H; Winchell HS
    J Nucl Med; 1971 Oct; 12(10):660-7. PubMed ID: 5000107
    [No Abstract]   [Full Text] [Related]  

  • 18. Familial hemochromatosis. Physiologic studies in the precirrhotic stage of the disease.
    Feller ER; Pont A; Wands JR; Carter EA; Foster G; Kourides IA; Isselbacher KJ
    N Engl J Med; 1977 Jun; 296(25):1422-6. PubMed ID: 194151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient hepatic deposition of iron im primary hemochromatosis with iron deficiency following venesection.
    Pollycove M; Fawwaz RA; Winchell HS
    J Nucl Med; 1971 Jan; 12(1):28-30. PubMed ID: 5539902
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment of body-iron stores in cirrhosis and haemochromatosis with the differential ferrioxamine test.
    Smith PM; Studley F; Williams R
    Lancet; 1967 Jan; 1(7482):133-6. PubMed ID: 4163312
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.